-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $140 at Jefferies on 4Q Report, Jakafi Metrics
-
-
-
-
-
-
-
Competitor's IDO Partnership Bodes Well for Incyte (INCY), Jefferies Says
-
-
-
-
-
-
-
Notable Analyst Rating Changes 01/23: (ALU) (WLT) (STR) Upgraded; (F) (SNV) (DD) Downgraded
-
-
-
-
-
-
-
Jefferies Maintains a 'Buy' on Incyte (INCY); Remain Positive On Ruxolitinib Despite NEJM Letter
-
-
-
-
-
-
56,112 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All